Export 254 results:
Author Title Type [ Year
Filters: First Letter Of Title is S [Clear All Filters]
“Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.”, JAMA Pediatr, vol. 176, no. 3, pp. 253-261, 2022.
, “Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.”, Hum Vaccin Immunother, vol. 17, no. 2, pp. 554-559, 2021.
, “Safety, Immunogenicity, And Efficacy Of Ndv-3a Against Staphylococcus Aureus Colonization: A Phase 2 Vaccine Trial Among Us Army Infantry Trainees”, Vaccine, vol. 39, no. 23, pp. 3179-3188, 2021.
, “SCORE2 Report 17: Macular Thickness Fluctuations in anti-VEGF-Treated Patients with Central or Hemiretinal Vein Occlusion”, Graefes Arch Clin Exp Ophthalmol, 2021.
, “Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.”, N Engl J Med, 2020.
, “Safety and immunogenicity of three seasonal inactivated influenza vaccines among pregnant women and antibody persistence in their infants.”, Vaccine, vol. 38, no. 33, pp. 5355-5363, 2020.
, “SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.”, Am J Ophthalmol, vol. 222, pp. 185-193, 2020.
, “Spectral Domain Optical Coherence Tomography Predictors of Visual Acuity in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2).”, Ophthalmol Retina, 2020.
, “Structural and Volumetric Brain MRI Findings in Mild Traumatic Brain Injury.”, AJNR Am J Neuroradiol, vol. 41, no. 1, pp. 92-99, 2020.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
, “Safety and Differential Antibody and T-Cell Responses to the Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants.”, Am J Trop Med Hyg, vol. 100, no. 6, pp. 1433-1444, 2019.
, “Safety and Efficacy of a Novel Vaginal Anti-infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-blind, Phase 2, Controlled Trial.”, Clin Infect Dis, vol. 68, no. 5, pp. 803-809, 2019.
, “Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial.”, Lancet HIV, vol. 6, no. 5, pp. e297-e306, 2019.
, “Safety and immunogenicity of an 8 year interval heterologous prime-boost influenza A/H7N7-H7N9 vaccination.”, Vaccine, vol. 37, no. 19, pp. 2561-2568, 2019.
, “Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.”, Lancet Infect Dis, vol. 19, no. 9, pp. 1013-1022, 2019.
, “Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial.”, PLoS One, vol. 14, no. 9, p. e0222178, 2019.
, “Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.”, Vaccine, vol. 37, no. 36, pp. 5161-5170, 2019.
, “Strength through Structure: Defending a Structured Approach to Contraceptive Mandates in Clinical Research.”, Ethics Hum Res, vol. 41, no. 3, pp. 33-35, 2019.
, “Stroke Version 2.0 Common Data Element (CDE) Review: Updates to the National Institute of Neurological Disorders and Stroke (NINDS) CDEs for Stroke”, in American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 2019.
, “Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.”, Vaccines (Basel), vol. 8, no. 1, 2019.
, “Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women.”, Vaccine, vol. 36, no. 52, pp. 8054-8061, 2018.
, “Self-Management Measurement and Prediction of Clinical Outcomes in Pediatric Transplant.”, J Pediatr, vol. 193, pp. 128-133.e2, 2018.
, “Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial.”, Bone Marrow Transplant, vol. 53, no. 8, pp. 1038-1043, 2018.
,